CT-388 activates both GLP-1 and GIP receptors with a unique signaling profile: Signal-biased dual agonism: Potent cAMP signaling at both GLP-1R and GIPR Minimal to no beta-arrestin recruitment at either receptor Reduced receptor internalization and desensitization Potentially prolonged pharmacological activity GLP-1 receptor activation: Appetite suppression via hypothalamic and brainstem receptors Glucose-dependent insulin secretion Glucagon suppression Gastric emptying delay GIP receptor activation: Additional insulin sensitization Enhanced lipid metabolism Complementary appetite regulation Potential adipose tissue remodeling benefits The biased signaling mechanism is the key differentiator
Your PlexusDx clinician can recommend a meal-timing strategy based on your tolerance and genetic profile
Woman says she got pregnant while on Mounjaro: What to know about weight loss drugs and pregnancy Marcela Romero said she struggled with fertility issues, trying for three years to conceive with no luck
Masi D, Spoltore ME, Rossetti R, et al
Fever, vomiting, and reduced appetite deplete fluids and nutrients rapidly, and a compromised digestive system absorbs oral supplements poorly
This vaginal swab test is highly accurate in diagnosing gonorrhea, chlamydia and trichomonas